Jozo Delić

2.0k total citations
33 papers, 1.5k citations indexed

About

Jozo Delić is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Jozo Delić has authored 33 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Genetics. Recurrent topics in Jozo Delić's work include Chronic Lymphocytic Leukemia Research (12 papers), Ubiquitin and proteasome pathways (9 papers) and Cancer-related Molecular Pathways (9 papers). Jozo Delić is often cited by papers focused on Chronic Lymphocytic Leukemia Research (12 papers), Ubiquitin and proteasome pathways (9 papers) and Cancer-related Molecular Pathways (9 papers). Jozo Delić collaborates with scholars based in France, Japan and Czechia. Jozo Delić's co-authors include H Magdelénat, Hélène Merle‐Béral, Peggy Masdehors, Sylvie Chevillard, Satoshi Ōmura, Romain Grall, Rosine Onclercq, Maïté Coppey‐Moisan, J L Binet and Satoshi Ōmura and has published in prestigious journals such as Blood, The Journal of Immunology and Biomaterials.

In The Last Decade

Jozo Delić

33 papers receiving 1.5k citations

Peers

Countries citing papers authored by Jozo Delić

Since Specialization

Citations

This map shows the geographic impact of Jozo Delić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jozo Delić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jozo Delić more than expected).

Fields of papers citing papers by Jozo Delić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jozo Delić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jozo Delić. The network helps show where Jozo Delić may publish in the future.

Co-authorship network of co-authors of Jozo Delić

This figure shows the co-authorship network connecting the top 25 collaborators of Jozo Delić. A scholar is included among the top collaborators of Jozo Delić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jozo Delić. Jozo Delić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impairing the radioresistance of cancer cells by hydrogenated nanodiamonds 2015 ·Biomaterials ·Romain Grall, Hugues A. Girard, (unknown), Tristan Petit, C. Gesset, (unknown), Vincent Paget, Jozo Delić, Jean‐Charles Arnault, Sylvie Chevillard	57
2	Chemo-sensitizing effects of EP4 receptor-induced inactivation of nuclear factor-κB 2014 ·European Journal of Pharmacology ·Martina Gobec, (unknown), Jozo Delić, (unknown), Irena Mlinarič‐Raščan	9
3	Concomitant heterochromatinisation and down-regulation of gene expression unveils epigenetic silencing of RELBin an aggressive subset of chronic lymphocytic leukemia in males 2010 ·BMC Medical Genomics ·Jean‐Brice Marteau, O. Rigaud, Thibaut Brugat, Nathalie Gault, Laurent Vallat, Mogens Kruhøffer, Torben F. Ørntoft, Florence Nguyen‐Khac, Sylvie Chevillard, Hélène Merle‐Béral, Jozo Delić	11
4	Natural Phosphorylation of CD5 in Chronic Lymphocytic Leukemia B Cells and Analysis of CD5-Regulated Genes in a B Cell Line Suggest a Role for CD5 in Malignant Phenotype 2007 ·The Journal of Immunology ·Hélène Gary‐Gouy, (unknown), Jean‐Brice Marteau, Anne Marfaing‐Koka, Jozo Delić, Hélène Merle‐Béral, Pierre Galanaud, Ali Dalloul	42
5	New molecular markers in resistant B-CLL 2006 ·Leukemia & lymphoma ·Julien Bouley, Ludovic Deriano, Jozo Delić, Hélène Merle‐Béral	10
6	Mutagenicity of non‐homologous end joining DNA repair in a resistant subset of human chronic lymphocytic leukaemia B cells 2006 ·British Journal of Haematology ·Ludovic Deriano, Hélène Merle‐Béral, Olivier Guipaud, Laure Sabatier, Jozo Delić	11
7	Principle of Digital Imaging Microscopy 2003 ·Humana Press eBooks ·Maïté Coppey‐Moisan, Jozo Delić, H Magdelénat, J. Coppey	2
8	B-cell chronic lymphocytic leukaemia: a polymorphic family unified by genomic features 2003 ·The Lancet Oncology ·Olivier Guipaud, Ludovic Deriano, (unknown), Laurent Vallat, Laure Sabatier, Hélène Merle‐Béral, Jozo Delić	26
9	Clinical Efficacy of Irradiation in CLL Patients: Predictive Value of in Vitro Radio-induced Apoptosis 2002 ·Leukemia & lymphoma ·Didier Decaudin, Jozo Delić, J Dumont, G. Tertian, Emmanuel Blot, Bernard Dubray, C. Grandpeix, Régis Peffault de Latour, Jean‐Marc Cosset	3
10	High levels of chromosome aberrations correlate with impaired in vitro radiation-induced apoptosis and DNA repair in human B-chronic lymphocytic leukaemia cells 2002 ·International Journal of Radiation Biology ·(unknown), Claire Alapetite, Peggy Masdehors, Hélène Merle‐Béral, (unknown), Jozo Delić, Laure Sabatier	16
11	Chromosomal DNA and p53 Stability, Ubiquitin System and Apoptosis in B-CLL Lymphocytes 2001 ·Leukemia & lymphoma ·(unknown), Peggy Masdehors, Anthony Laugé, Dominique Stoppa‐Lyonnet, (unknown), Hélène Merle‐Béral, Jacques‐Louis Binet, Satoshi Ōmura, H Magdelénat, Laure Sabatier, Jozo Delić	9
12	Ubiquitin-Proteasome System and Increased Sensitivity of B-CLL Lymphocytes to Apoptotic Death Activation 2000 ·Leukemia & lymphoma ·Peggy Masdehors, Hélène Merle‐Béral, H Magdelénat, Jozo Delić	40
13	Cell cycle regulation of the endogenous wild type Bloom's syndrome DNA helicase 2000 ·Oncogene ·Stéphanie Dutertre, (unknown), Rosine Onclercq, Jozo Delić, Bruno Chatton, Christian Jaulin, Mounira Amor-Guéret	96
14	Increased sensitivity of CLL‐derived lymphocytes to apoptotic death activation by the proteasome‐specific inhibitor lactacystin 1999 ·British Journal of Haematology ·Peggy Masdehors, Satoshi Ōmura, Hélène Merle‐Béral, (unknown), Jean‐Marc Cosset, (unknown), H Magdelénat, Jozo Delić	105
15	In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in non-Hodgkin's lymphomas 1998 ·Radiotherapy and Oncology ·Bernard Dubray, (unknown), Jozo Delić, Jerzy Klijanienko, Zofia Maciorowski, Philippe Vielh, Alain Fourquet, J Dumont, H Magdelénat, Jean‐Marc Cosset	62
16	Comparative analysis of apoptosis measured by Hoechst and flow cytometry in non-Hodgkin's lymphomas 1998 ·Cytometry ·Zofia Maciorowski, Jozo Delić, (unknown), Jerzy Klijanienko, Bernard Dubray, (unknown), J Dumont, (unknown), Philippe Vielh	26
17	γ-Ray-induced Transcription and Apoptosis-associated Loss of 28S rRNA in Interphase Human Lymphocytes 1993 ·International Journal of Radiation Biology ·Jozo Delić, Maïté Coppey‐Moisan, H Magdelénat	24
18	Inhibition and enhancement of eukaryotic gene expression by potential non-B DNA sequences 1991 ·Biochemical and Biophysical Research Communications ·Jozo Delić, Rosine Onclercq, (unknown)	23
19	Inhibition and enhancement of eukaryotic gene expression by potential non-B DNA sequences 1991 ·Biochemical and Biophysical Research Communications ·Jozo Delić, Rosine Onclercq, (unknown)	11
20	Impossibility of acridine orange intercalation in nuclear DNA of the living cell 1991 ·Experimental Cell Research ·Jozo Delić, J. Coppey, H Magdelénat, Maïté Coppey‐Moisan	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact